SMTL ID : 3upr.2 (1 other biounit)

HLA-B*57:01 complexed to pep-V and Abacavir

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.00 Å

Oligo State

hetero-1-1-mer

Ligands

1 x HIS- SER- ILE- THR- TYR- LEU- LEU- PRO- VAL: pep-V(Non-covalent)

HIS-SER-ILE-THR-TYR-LEU-LEU-PRO-VAL.1: 24 residues within 4Å: Chain A: M.6, Y.8, Y.10, Y.60, E.64, N.67, M.68, A.70, S.71, T.74, N.78, I.81, Y.85, Y.100, T.144, K.147, W.148, V.153, Q.156, L.157, Y.160, W.168, Y.172 Ligands: 1KX.2 20 PLIP interactions: 20 interactions with chain A Hydrophobic interactions: A:Y.100, A:W.148, A:V.153, A:Q.156, A:L.157, A:Y.160, A:Y.160, A:Y.160, A:W.168 Hydrogen bonds: A:E.64, A:N.67, A:N.78, A:N.78, A:Y.85, A:Y.100, A:T.144, A:Y.160, A:Y.172 Water bridges: A:K.147 Salt bridges: A:K.147

1 x 1KX: {(1S,4R)-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]cyclopent-2-en-1-yl}methanol(Non-covalent)

1KX.2: 16 residues within 4Å: Chain A: Y.10, Y.75, I.96, V.98, Y.100, D.115, Q.116, S.117, A.118, Y.124, I.125, W.148 Ligands: HIS-SER-ILE-THR-TYR-LEU-LEU-PRO-VAL.1, HIS-SER-ILE-THR-TYR-LEU-LEU-PRO-VAL.1, HIS-SER-ILE-THR-TYR-LEU-LEU-PRO-VAL.1, HIS-SER-ILE-THR-TYR-LEU-LEU-PRO-VAL.1 12 PLIP interactions: 12 interactions with chain A Hydrophobic interactions: A:I.96, A:I.96, A:V.98, A:Y.100, A:Y.124 Hydrogen bonds: A:D.115, A:S.117 Water bridges: A:N.78, A:N.78, A:N.78 Salt bridges: A:D.115 pi-Stacking: A:W.148

1 x CL: CHLORIDE ION(Non-functional Binders)

CL.3: 1 residues within 4Å: Chain A: R.146 Ligand excluded by PLIP

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Ostrov, D.A. et al., Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire. Proc.Natl.Acad.Sci.USA (2012)

Release Date

2012-06-13

Peptides

HLA class I histocompatibility antigen, B-57 alpha chain: A
Beta-2-microglobulin: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
C

B
D

HLA class I histocompatibility antigen, B-57 alpha chain

Beta-2-microglobulin

Related Entries With Identical Sequence